Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study. [electronic resource]
Producer: 20200414Description: E204-E210 p. digitalISSN:- 1522-726X
- Aged
- Blood Platelets -- drug effects
- Drug Therapy, Combination
- Female
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Practice Patterns, Physicians'
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Receptors, Purinergic P2Y12 -- blood
- Recurrence
- Risk Factors
- Stroke -- mortality
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.